Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Lymphoid 1Head & Neck 1Gastrointestinal 1Breast 1

Conditions

Carcinoma, Non-Small-Cell Lung 3NSCLC 2Triple Negative Breast Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1Lymphoma 1Lung Neoplasms 1Hodgkin Disease 1Esophageal Neoplasms 1Colorectal Neoplasms 1Burkitt Lymphoma 1

Interventions

Gemcitabine 2vandetanib 1temsirolimus 1sargramostim 1motexafin gadolinium 1motesanib diphosphate 1entinostat 1carboxyamido-triazole 1Watchful Waiting 1Topotecan 1Thalidomide 1Ritonavir 1Radiotherapy 1Polymerase Chain Reaction 1Paclitaxel 1Nicotine 1Microarray Analysis 1Metformin 1Levofloxacin 1Leucovorin 1Indinavir 1Immunotherapy, Adoptive 1Immunoenzyme Techniques 1HMPL-013 1Gene Expression Profiling 1Fluorouracil 1Flow Cytometry 1Fentanyl 1Etoposide 1Doxorubicin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Burkitt Lymphoma × HMPL-013 × Thoracic × Clear all
NCT05565417 2025-10-16

Study of the Monoclonal Antibody IMT-009 in Patients With Advanced Solid Tumors or Lymphomas

Immunitas Therapeutics

Phase 1/2 Active not recruiting
67 enrolled
BreastGastrointestinalHead & NeckLymphoidThoracic

Squamous Cell Carcinoma of Head and Neck, Burkitt Lymphoma, Carcinoma, Non-Small-Cell Lung, Esophageal Neoplasms, Hodgkin Disease, Lymphoma, Lymphoma, Follicular, Colorectal Neoplasms, Lymphoma, Large B-Cell, Diffuse, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡